Aprea Therapeutics Inc (APRE)

Precedente Chiudi:

$4.4056

Aprire:

$4.3

Volume 24 ore:

33,427

Capitalizzazione di mercato:

$22.81M

Reddito:

-

Utile/perdita netta:

$-14.29M

Rapporto P/E:

-0.7595

EPS:

-5.53

Flusso di cassa netto:

$-12.27M

1 W Prestazione:

-4.76%

1M Prestazione:

-20.30%

6M Prestazione:

+9.38%

1 anno Prestazione:

+17.98%

Intervallo 1D:

$4.10

$4.475

Portata 52W:

$2.78

$8.8465

Aprea Therapeutics Inc Stock (APRE) Company Profile

Nome

Aprea Therapeutics Inc

Settore

Healthcare (1206)

Industria

Biotechnology (699)

Telefono

617 463 9385

Indirizzo

3805 Old Easton Road, Doylestown, MA

Dipendente

0

Cinguettio

Prossima data di guadagno

2024-06-13

Ultimi documenti SEC

APRE's Discussions on Twitter

Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-12-28	Downgrade	Robert W. Baird	Outperform → Neutral
2020-12-16	Iniziato	Berenberg	Buy
2020-09-29	Ripresa	JP Morgan	Neutral
2020-06-22	Iniziato	H.C. Wainwright	Neutral
2020-04-21	Iniziato	Robert W. Baird	Outperform
2019-10-28	Iniziato	JP Morgan	Neutral
2019-10-28	Iniziato	Morgan Stanley	Equal-Weight
2019-10-28	Iniziato	RBC Capital Mkts	Outperform

Mostra tutto

Aprea Therapeutics Inc Borsa (APRE) Ultime notizie

Aprea Therapeutics (NASDAQ:APRE) Given Buy Rating at HC Wainwright - Defense World

Defense World

Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor ... - StockTitan

StockTitan

Amplitude, Inc. (NASDAQ:AMPL) Short Interest Up 34.5% in May - Defense World

Defense World

Apogee Therapeutics, Inc. (NASDAQ:APGE) Short Interest Up 36.0% in May - Defense World

Defense World

Short Interest in Aprea Therapeutics, Inc. (NASDAQ:APRE) Decreases By 34.6% - Defense World

Defense World

Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Rises By 47.0% - Defense World

Defense World

Aprea Therapeutics Inc Azioni (APRE) Dati Finanziari

Aprea Therapeutics Inc (APRE) Reddito netto 2024

Aprea Therapeutics Inc (APRE) Flusso di cassa 2024

Aprea Therapeutics Inc (APRE) Utile per azione 2024